tirzepatide thigh injection video Training Where and How to Inject

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management in adults (Mounjaro) and chronic weight management (Zepbound) in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity

This association was identified in female mice only

But proteins break down when they get too warm

That finding is in line with new Mercer research that found that, despite nearly half of employers now covering the drugs for weight loss, about 6% will eliminate that benefit this year, and 5% plan to make cuts in 2027

For women, Svendsen says there is also power in combining GLP-1s with hormone replacement therapy

Clinical trials have reported that individuals typically lose 10%-15% of their baseline body weight after 12 years